When polycythemia is observed in patients with SCLC, clinicians should consider not only the possibility of hypoxia or hematologic disorders but also evaluate for recurrence, metastasis, and the potential for ectopic EPO production. The gene discussed is EPO; the disease is hematologic disorder.